First Time Loading...

GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 715.5 GBX 0.62%
Updated: May 2, 2024

Wall Street
Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 1 882.1 GBX with a low forecast of 1 212 GBX and a high forecast of 2 656.5 GBX.

Lowest
Price Target
1 212 GBX
29% Downside
Average
Price Target
1 882.1 GBX
10% Upside
Highest
Price Target
2 656.5 GBX
55% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
GRANULES
Granules India Ltd
7% Upside
106190
High Tech Pharm Co Ltd
140% Upside
HYPE3
Hypera SA
50% Upside
GHRS
GH Research PLC
171% Upside
SCTL
Societal CDMO Inc
2% Upside
MRK
Merck & Co Inc
9% Upside

Revenue
Forecast

Revenue Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 3%. The projected CAGR for the next 3 years is 6%.

3%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 7%. The projected CAGR for the next 3 years is 10%.

7%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -6%. The projected CAGR for the next 3 years is 18%.

-6%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSK's stock price target?
Price Target
1 882.1 GBX

According to Wall Street analysts, the average 1-year price target for GSK is 1 882.1 GBX with a low forecast of 1 212 GBX and a high forecast of 2 656.5 GBX.

What is GlaxoSmithKline PLC's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 3%. The projected CAGR for the next 3 years is 6%.

What is GlaxoSmithKline PLC's Operating Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 7%. The projected CAGR for the next 3 years is 10%.

What is GlaxoSmithKline PLC's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -6%. The projected CAGR for the next 3 years is 18%.